INS and Hepatic steatosis: The clinical phenotype of patients with NAFLD alone in our study, characterized by a lower prevalence of cardiovascular comorbidities, lower use of insulin, and high GGT values, suggest that these patients may have a liver steatosis not strictly correlated to metabolic abnormalities, but rather to a genetic predisposition.